From proteomic analysis to clinical significance: Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis

Molecular and Cellular Proteomics

Volumn 3, Issue 1, 2004, Pages 73-81

  Ding, Shi Jian ^a   Li, Yan ^b   Tan, Ye Xiong ^c   Jiang, Man Rong ^a   Tian, Bo ^b   Liu, Ying Kun ^b   Shao, Xiao Xia ^a   Ye, Sheng Long ^b   Wu, Jia Rui ^a   Zeng, Rong ^a   Wang, Hong Yang ^c   Tang, Zhao You ^b   Xia, Qi Chang ^a  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

^c E Hepatobiliary Surgery Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 19 FRAGMENT;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CELL STRAIN; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; TUMOR EMBOLISM; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULAR TUMOR; WESTERN BLOTTING;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; KERATINS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; PROTEOME; RANDOM ALLOCATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

MUS MUSCULUS;

EID: 2542608297     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M300094-MCP200     Document Type: Article

References (41)

1. Tang, Z. Y. (2000) Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol. Today 4, 191-195
2. Qin, X. L., and Tang, Z. Y. (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 8, 193-199
3. Tian, J., Tang, Z. Y., Ye, S. L., Liu, Y. K., Lin, Z. Y., Chen, J., and Xue, Q. (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br. J. Cancer 81, 814-818
4. Li, Y., Tang, Z. Y., Ye, S. L., Liu, Y. K., Chen, J., Xue, Q., Chen, J., Gao, D. M., and Bao, W. H. (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J. Gastroenterol. 7, 630-636
5. Li, Y., Tang, Z. Y., Ye, S. L., Lilu, B. B, Liu, Y. K., Chen, J., and Xue, Q. (2003) Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol. 129, 43-51
6. Simpson, R. J., and Dorow, D. S. (2001) Cancer proteomics: from signaling networks to tumor markers. Trends Biotech. 19, 40-48
7. Yu, L. R., Zeng, R., Shao, X. X., Wang, N., Xu, Y. H., and Xia, Q. C. (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21, 3058-3068
8. Yu, L. R., Shao, X. X., Jiang, W. L., Xu, D., Chang, Y. C., Xu, Y. H., and Xia, Q. C. (2001) Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence. Electrophoresis 22, 3001-3008
9. Moll, R., Franke, W. W., and Schiller, D. L. (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11-24
10. Paladini, R. D., Takahashi, K., Bravo, N. S., and Coulombe, P. A. (1996) Onset of reepithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J. Cell Biol. 132, 381-397
11. Chu, Y. W., Runyan, R. B., Oshima, R. G., and Hendrix, M. J. (1993) Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. U. S. A., 90, 4261-4265
12. Hendrix, M. J., Seftor, E. A., Chu, Y. W., Trevor, K. T., and Seftor, R. E. (1996) Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15, 507-525
13. Crowe, D. L., Milo, G. E., and Shuler, C. F. (1999) Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J. Dent. Res., 78, 1256-1263
14. A. J. Link. (1999) 2-D Proteome Analysis Protocols, pp. 99-103, Humana Press, Totowa, NJ
15. Yan, J. X., Wait, R., Berkelman, T, Harry, R. A., Westbrook, J. A., Wheeler, C. H., and Dunn M. J. (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assited laser desorption/ionization and electrospray ionization mass spectrometry. Electrophoresis 21, 3666-3672
16. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858
17. Pollock, R. E. (2002) Manual of Clinical Oncology, 6th Ed., pp. 166-167, Wiley-Liss, New York
18. Ding, S. J., Li, Y., Shao, X. X., Zhou, H., Zeng, R., Tang, Z. Y., and Xia, Q. C. (2004) Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics, in press
19. Qin, L. X., and Tang, Z. Y. (2002) The prognostic molecular markers in hepatocellular carcinoma World J. Gastroenterol. 8, 385-392
20. Weber, J. C., Nakano, H., Bachellier, P., Oussoultzoglou, E., Inoue, K., Shimura, H., Wolf, P., Chenard-Neu, M. P., and Jaeck, D. (2001) Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am. J. Surg. 182, 81-88
21. Huang, G. T., Lee, H. S., Chen, C. H., Sheu, J. C., Chiou, L. L., and Chen, D. S. (1999) Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterology 46, 1923-1927
22. Endo, K., Ueda, T., Ueyama, J., Ohta, T., and Terada, T. (2000) Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum. Pathol. 31, 558-565
23. Zheng, Q., Tang, Z. Y., Xue, Q., Shi, D. R., Song, H. Y., and Tang, H. B. (2000) Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor. J. Cancer Res. Clin. Oncol. 126, 641-646
24. Li, X. M., Tang, Z. Y., Qin, L. X., Zhou, J., and Sun, H. C. (1999) Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 18, 511-517
25. Minata, M., Nishida, N., Komeda, T., Azechi, H., Katsuma, H., Nishimura, T., Kuno, M., Ito, T., Yamamoto, Y., Ikai, I., Yamaoka, Y., Fukuda, Y., and Nakao, K. (2001) Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 16, 445-451
26. Stosiek, P., Kasper, M., and Karsten, U. (1990) Expression of cytokeratin 19 during human liver organogenesis. Liver 10, 59-63
27. Fischer, H. P., Altmannsberger, M., Weber, K., and Osborn, M. (1987) Keratin polypeptides in malignant epithelial liver tumors. Am. J. Pathol. 127, 530-537
28. Balaton, A. J., Nehama-Sibony, M., Gotheil, C., Callard, P., and Baviera, E. E. (1988) Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections. J. Pathol. 156, 305-310
29. Wu, F., Nishioka, M., Fujita, J., Murota, M., Ohtsuki, Y., Ishida, T., and Kuriyama, S. (2002) Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines. Int. J. Oncol. 20, 31-37
30. Wu, P. C., Fang, J. W. S., Lau, V. K. T., Lai, C. L., Lo, C. K., and Lau, J. Y. N. (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Am. J. Pathol. 149, 1167-1175
31. Eyken, van. P., Sciot, R., Callea, F., Ramaekers, F., Schaart, C., and Desmet, V. J. (1990) A cytokeratin-immunohistological study of hepatocellular carcinoma. Hum. Pathol. 21, 302-308
32. Green, J. A., Carthew, P., Heuillet, E., Simpson, J. L., and Manson, M. M. (1990) Cytokeratin expression during AFB1-induced carcinogenesis. Carcinogenesis 11, 1175-1182
33. Pujol, J. L., Grenier, J., Daures J. P., Daver, A., Pujol, H., and Michel, F. B. (1993) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer, Cancer Res. 53, 61-66
34. Nakata, B., Ogawa, Y., Ishikawa, T., Ikeda, K., Kato, Y., Nishino, H., and Hirakawa, K. (2000) Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma. Cancer 89, 1285-1290
35. Gadducci, A., Ferdeghini, M., Cosio, S., Fanucchi, A., Cristofani, R., and Genazzani, A. R. (2001) The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer. Int. J. Gynecol. Cancer 11, 277-282
36. Sanchez-Carbayo M, Espasa, A., Chinchilla, V., Herrero, E., Megias, J., Mira, A., Soria, F. (1999) New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: Analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer. Clin. Chem. 45, 1944-1953
37. Nagai, T., Murota, M., Nishioka, M., Fujita, J., Ohtsuki, Y., Dohmoto, K., Hojo, S., Dobashi, N., and Takahara, J. (2001) Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: Its clinical significance. Eur. J. Gastroenterol. Hepatol. 13, 157-161
38. Uenishi, T., Kubo, S., Hirohashi, K., Tanaka, H., Shuto, T., Yamamoto, T., and Nishiguchi, S. (2003) Cytokerain 19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br. J. Cancer 88, 1894-1899
39. Wu, F., Fujita, J., Murota, M., Li, J. Q., Ishida, T., Nishioka, M., Imaida, Y., Kuriyama, S. (2002) CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7. Int. J. Oncol. 21, 441-445
40. Satoh, H., Ishikawa, H., Fujiwara, M., Yamashita, Y. T., Ohtsuka, M., Ogata, T., Hasegawa, S., and Kamma, H. (1997) Production of cytokeratin 19 fragment by human squamous lung cancer cell lines. Am. J. Res. Cell. Mol. Biol. 16, 597-604
41. Dobashi, N., Fujita, J., Murota, M., Ohtsuki, Y., Bandoh, S., Ueda, Y., Dohmoto, K., Hojo, S., Nishioka, M., Ishida, T., and Takahara, J. (2000) Binding of recombinant human cytokeratin 19 to laminin: A possible role in interaction between intermediate filament derived from epithelial cells and extracellular matrixes. Cell Structure Function 25, 171-175